The growing popularity of regenerative medicines & cell therapies coupled with a range of benefits offered by automation technologies for the development of these therapies is expected to propel the market growth.
Highlights
The global Automated And Closed Cell Therapy Processing Systems market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Automated And Closed Cell Therapy Processing Systems is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Automated And Closed Cell Therapy Processing Systems is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Automated And Closed Cell Therapy Processing Systems in Pre-commercial/R&D Scale is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Automated And Closed Cell Therapy Processing Systems include MiltenyiBiotec, Lonza, Fresenius Kabi, Cytiva (Danaher Corp.), BioSpherix, Ltd., Terumo Corporation, Sartorius AG, ThermoGenesis Holdings, Inc. and Cellares Inc., etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Automated And Closed Cell Therapy Processing Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automated And Closed Cell Therapy Processing Systems.
The Automated And Closed Cell Therapy Processing Systems market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Automated And Closed Cell Therapy Processing Systems market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Automated And Closed Cell Therapy Processing Systems companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
MiltenyiBiotec
Lonza
Fresenius Kabi
Cytiva (Danaher Corp.)
BioSpherix, Ltd.
Terumo Corporation
Sartorius AG
ThermoGenesis Holdings, Inc.
Cellares Inc.
Thermo Fisher Scientific, Inc.
Segment by Type
Stem Cell Therapy
Non-Stem Cell Therapy
Segment by Application
Pre-commercial/R&D Scale
Commercial Scale
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Automated And Closed Cell Therapy Processing Systems companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Automated And Closed Cell Therapy Processing Systems Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Stem Cell Therapy
1.2.3 Non-Stem Cell Therapy
1.3 Market by Application
1.3.1 Global Automated And Closed Cell Therapy Processing Systems Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pre-commercial/R&D Scale
1.3.3 Commercial Scale
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Automated And Closed Cell Therapy Processing Systems Market Perspective (2018-2029)
2.2 Automated And Closed Cell Therapy Processing Systems Growth Trends by Region
2.2.1 Global Automated And Closed Cell Therapy Processing Systems Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Automated And Closed Cell Therapy Processing Systems Historic Market Size by Region (2018-2023)
2.2.3 Automated And Closed Cell Therapy Processing Systems Forecasted Market Size by Region (2024-2029)
2.3 Automated And Closed Cell Therapy Processing Systems Market Dynamics
2.3.1 Automated And Closed Cell Therapy Processing Systems Industry Trends
2.3.2 Automated And Closed Cell Therapy Processing Systems Market Drivers
2.3.3 Automated And Closed Cell Therapy Processing Systems Market Challenges
2.3.4 Automated And Closed Cell Therapy Processing Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Automated And Closed Cell Therapy Processing Systems Players by Revenue
3.1.1 Global Top Automated And Closed Cell Therapy Processing Systems Players by Revenue (2018-2023)
3.1.2 Global Automated And Closed Cell Therapy Processing Systems Revenue Market Share by Players (2018-2023)
3.2 Global Automated And Closed Cell Therapy Processing Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Automated And Closed Cell Therapy Processing Systems Revenue
3.4 Global Automated And Closed Cell Therapy Processing Systems Market Concentration Ratio
3.4.1 Global Automated And Closed Cell Therapy Processing Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Automated And Closed Cell Therapy Processing Systems Revenue in 2022
3.5 Automated And Closed Cell Therapy Processing Systems Key Players Head office and Area Served
3.6 Key Players Automated And Closed Cell Therapy Processing Systems Product Solution and Service
3.7 Date of Enter into Automated And Closed Cell Therapy Processing Systems Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Automated And Closed Cell Therapy Processing Systems Breakdown Data by Type
4.1 Global Automated And Closed Cell Therapy Processing Systems Historic Market Size by Type (2018-2023)
4.2 Global Automated And Closed Cell Therapy Processing Systems Forecasted Market Size by Type (2024-2029)
5 Automated And Closed Cell Therapy Processing Systems Breakdown Data by Application
5.1 Global Automated And Closed Cell Therapy Processing Systems Historic Market Size by Application (2018-2023)
5.2 Global Automated And Closed Cell Therapy Processing Systems Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Automated And Closed Cell Therapy Processing Systems Market Size (2018-2029)
6.2 North America Automated And Closed Cell Therapy Processing Systems Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Automated And Closed Cell Therapy Processing Systems Market Size by Country (2018-2023)
6.4 North America Automated And Closed Cell Therapy Processing Systems Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Automated And Closed Cell Therapy Processing Systems Market Size (2018-2029)
7.2 Europe Automated And Closed Cell Therapy Processing Systems Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Automated And Closed Cell Therapy Processing Systems Market Size by Country (2018-2023)
7.4 Europe Automated And Closed Cell Therapy Processing Systems Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Size (2018-2029)
8.2 Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Size by Region (2018-2023)
8.4 Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Automated And Closed Cell Therapy Processing Systems Market Size (2018-2029)
9.2 Latin America Automated And Closed Cell Therapy Processing Systems Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Automated And Closed Cell Therapy Processing Systems Market Size by Country (2018-2023)
9.4 Latin America Automated And Closed Cell Therapy Processing Systems Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Size (2018-2029)
10.2 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Size by Country (2018-2023)
10.4 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 MiltenyiBiotec
11.1.1 MiltenyiBiotec Company Detail
11.1.2 MiltenyiBiotec Business Overview
11.1.3 MiltenyiBiotec Automated And Closed Cell Therapy Processing Systems Introduction
11.1.4 MiltenyiBiotec Revenue in Automated And Closed Cell Therapy Processing Systems Business (2018-2023)
11.1.5 MiltenyiBiotec Recent Development
11.2 Lonza
11.2.1 Lonza Company Detail
11.2.2 Lonza Business Overview
11.2.3 Lonza Automated And Closed Cell Therapy Processing Systems Introduction
11.2.4 Lonza Revenue in Automated And Closed Cell Therapy Processing Systems Business (2018-2023)
11.2.5 Lonza Recent Development
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Company Detail
11.3.2 Fresenius Kabi Business Overview
11.3.3 Fresenius Kabi Automated And Closed Cell Therapy Processing Systems Introduction
11.3.4 Fresenius Kabi Revenue in Automated And Closed Cell Therapy Processing Systems Business (2018-2023)
11.3.5 Fresenius Kabi Recent Development
11.4 Cytiva (Danaher Corp.)
11.4.1 Cytiva (Danaher Corp.) Company Detail
11.4.2 Cytiva (Danaher Corp.) Business Overview
11.4.3 Cytiva (Danaher Corp.) Automated And Closed Cell Therapy Processing Systems Introduction
11.4.4 Cytiva (Danaher Corp.) Revenue in Automated And Closed Cell Therapy Processing Systems Business (2018-2023)
11.4.5 Cytiva (Danaher Corp.) Recent Development
11.5 BioSpherix, Ltd.
11.5.1 BioSpherix, Ltd. Company Detail
11.5.2 BioSpherix, Ltd. Business Overview
11.5.3 BioSpherix, Ltd. Automated And Closed Cell Therapy Processing Systems Introduction
11.5.4 BioSpherix, Ltd. Revenue in Automated And Closed Cell Therapy Processing Systems Business (2018-2023)
11.5.5 BioSpherix, Ltd. Recent Development
11.6 Terumo Corporation
11.6.1 Terumo Corporation Company Detail
11.6.2 Terumo Corporation Business Overview
11.6.3 Terumo Corporation Automated And Closed Cell Therapy Processing Systems Introduction
11.6.4 Terumo Corporation Revenue in Automated And Closed Cell Therapy Processing Systems Business (2018-2023)
11.6.5 Terumo Corporation Recent Development
11.7 Sartorius AG
11.7.1 Sartorius AG Company Detail
11.7.2 Sartorius AG Business Overview
11.7.3 Sartorius AG Automated And Closed Cell Therapy Processing Systems Introduction
11.7.4 Sartorius AG Revenue in Automated And Closed Cell Therapy Processing Systems Business (2018-2023)
11.7.5 Sartorius AG Recent Development
11.8 ThermoGenesis Holdings, Inc.
11.8.1 ThermoGenesis Holdings, Inc. Company Detail
11.8.2 ThermoGenesis Holdings, Inc. Business Overview
11.8.3 ThermoGenesis Holdings, Inc. Automated And Closed Cell Therapy Processing Systems Introduction
11.8.4 ThermoGenesis Holdings, Inc. Revenue in Automated And Closed Cell Therapy Processing Systems Business (2018-2023)
11.8.5 ThermoGenesis Holdings, Inc. Recent Development
11.9 Cellares Inc.
11.9.1 Cellares Inc. Company Detail
11.9.2 Cellares Inc. Business Overview
11.9.3 Cellares Inc. Automated And Closed Cell Therapy Processing Systems Introduction
11.9.4 Cellares Inc. Revenue in Automated And Closed Cell Therapy Processing Systems Business (2018-2023)
11.9.5 Cellares Inc. Recent Development
11.10 Thermo Fisher Scientific, Inc.
11.10.1 Thermo Fisher Scientific, Inc. Company Detail
11.10.2 Thermo Fisher Scientific, Inc. Business Overview
11.10.3 Thermo Fisher Scientific, Inc. Automated And Closed Cell Therapy Processing Systems Introduction
11.10.4 Thermo Fisher Scientific, Inc. Revenue in Automated And Closed Cell Therapy Processing Systems Business (2018-2023)
11.10.5 Thermo Fisher Scientific, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
MiltenyiBiotec
Lonza
Fresenius Kabi
Cytiva (Danaher Corp.)
BioSpherix, Ltd.
Terumo Corporation
Sartorius AG
ThermoGenesis Holdings, Inc.
Cellares Inc.
Thermo Fisher Scientific, Inc.
听
听
*If Applicable.
